Loading...
Please wait, while we are loading the content...
Similar Documents
Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
| Content Provider | MDPI |
|---|---|
| Author | Phelan, Thomas Dunne, Jean Conlon, Niall Cheallaigh, ClĂona Abbott, W. Faba-Rodriguez, Raquel Amanat, Fatima Krammer, Florian Little, Mark Hughes, Gerry Bergin, Colm Kerr, Colm Sundaresan, Sudharshana Long, Aideen McCormack, William Brady, Gareth |
| Copyright Year | 2021 |
| Description | Serological assays have been widely employed during the coronavirus disease 2019 (COVID-19) pandemic to measure antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to track seroconversion in populations. However, currently available assays do not allow determination of neutralization capacity within the assay protocol. Furthermore, commercial serology assays have a high buy-in cost that is inaccessible for many research groups. We have replicated the serological enzyme-linked immunosorbent assay for the detection of SARS-CoV-2 antibody isotypes, developed at the Icahn School of Medicine at Mount Sinai, New York. Additionally, we have modified the protocol to include a neutralization assay with only a minor modification to this protocol. We used this assay to screen local COVID-19 patient sera (n = 91) and pre-COVID-19 control sera (n = 103), and obtained approximate parity with approved commercial anti-nucleoprotein-based assays with these sera. Furthermore, data from our neutralization assay closely aligns with that generated using a spike-based pseudovirus infection model when a subset of patient sera was analyzed. |
| Starting Page | 1371 |
| e-ISSN | 19994915 |
| DOI | 10.3390/v13071371 |
| Journal | Viruses |
| Issue Number | 7 |
| Volume Number | 13 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-07-15 |
| Access Restriction | Open |
| Subject Keyword | Viruses Infectious Diseases Antibody Enzyme-linked Immunosorbent Assay Neutralization Sars-cov-2 Serology Pseudovirus Infection Model |
| Content Type | Text |
| Resource Type | Article |